Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review.
Lubrano E, Spadaro A, Amato G, Benucci M, Cavazzana I, Chimenti MS, Ciancio G, D Alessandro G, Angelis R, Lupoli S, Lurati AM, Naclerio C, Russo R, Semeraro A, Tomietto P, Zuccaro C, De Marco G. Lubrano E, et al. Among authors: naclerio c. Semin Arthritis Rheum. 2015 Apr;44(5):542-550. doi: 10.1016/j.semarthrit.2014.09.012. Epub 2014 Sep 28. Semin Arthritis Rheum. 2015. PMID: 25450240 Review.
Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE study.
Serban T, Allara R, Azzolini V, Bellintani C, Belloli L, Belai Beyene N, Bucci R, Caporali R, Cappelli A, Corbelli V, DE Gennaro F, Fusaro E, Giusti A, Govoni M, Magnani L, Manzo C, Romano C, Rossini M, Santilli D, Saviola G, Sinigaglia L, Bianchi G; MARTE study group. Serban T, et al. Minerva Med. 2021 Apr;112(2):246-254. doi: 10.23736/S0026-4806.21.06902-0. Epub 2021 Feb 8. Minerva Med. 2021. PMID: 33555152
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
Ferri C, Gragnani L, Raimondo V, Visentini M, Giuggioli D, Lorini S, Foti R, Cacciapaglia F, Caminiti M, Olivo D, Cuomo G, Pellegrini R, Pigatto E, Urraro T, Naclerio C, Tavoni A, Puccetti L, Cavazzana I, Ruscitti P, Vadacca M, La Gualana F, Cozzi F, Spinella A, Visalli E, Bosco YD, Amato G, Masini F, Mariano GP, Brittelli R, Aiello V, Scorpiniti D, Rechichi G, Varcasia G, Monti M, Elia G, Franceschini F, Casato M, Ursini F, Giacomelli R, Fallahi P, Santini SA, Iannone F, Salvarani C, Zignego AL, Antonelli A. Ferri C, et al. Among authors: naclerio c. J Autoimmun. 2022 Jul;131:102866. doi: 10.1016/j.jaut.2022.102866. Epub 2022 Jul 11. J Autoimmun. 2022. PMID: 35841684 Free PMC article.
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G. De Vita S, et al. Among authors: naclerio c. Arthritis Rheum. 2012 Mar;64(3):843-53. doi: 10.1002/art.34331. Arthritis Rheum. 2012. PMID: 22147661 Free article. Clinical Trial.
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
Ferri C, Ursini F, Gragnani L, Raimondo V, Giuggioli D, Foti R, Caminiti M, Olivo D, Cuomo G, Visentini M, Cacciapaglia F, Pellegrini R, Pigatto E, Urraro T, Naclerio C, Tavoni A, Puccetti L, Varcasia G, Cavazzana I, L'Andolina M, Ruscitti P, Vadacca M, Gigliotti P, La Gualana F, Cozzi F, Spinella A, Visalli E, Dal Bosco Y, Amato G, Masini F, Pagano Mariano G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Rechichi G, Ferrari T, Monti M, Elia G, Franceschini F, Meliconi R, Casato M, Iannone F, Giacomelli R, Fallahi P, Santini SA, Zignego AL, Antonelli A. Ferri C, et al. Among authors: naclerio c. J Autoimmun. 2021 Dec;125:102744. doi: 10.1016/j.jaut.2021.102744. Epub 2021 Nov 10. J Autoimmun. 2021. PMID: 34781162 Free PMC article.
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group.
Ursini F, Ruscitti P, Addimanda O, Foti R, Raimondo V, Murdaca G, Caira V, Pigatto E, Cuomo G, Lo Gullo A, Cavazzana I, Campochiaro C, Naclerio C, De Angelis R, Ciaffi J, Mancarella L, Brusi V, Marchetti E, Motta F, Visentini M, Lorusso S, De Santis M, De Luca G, Massaro L, Olivo D, Pellegrini R, Francioso F, Luppino J, Di Cola I, Foti R, Varcasia G, Caso F, Reta M, Dagna L, Selmi C, Iagnocco A, Giacomelli R, Iannone F, Ferri C. Ursini F, et al. Among authors: naclerio c. RMD Open. 2023 Jun;9(2):e003022. doi: 10.1136/rmdopen-2023-003022. RMD Open. 2023. PMID: 37328292 Free PMC article.
Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters.
Caserta L, de Magistris L, Secondulfo M, Caravelli G, Riegler G, Cuomo G, D'Angelo S, Naclerio C, Valentini G, Carratù R. Caserta L, et al. Among authors: naclerio c. Rheumatol Int. 2003 Sep;23(5):226-30. doi: 10.1007/s00296-003-0286-3. Epub 2003 Feb 15. Rheumatol Int. 2003. PMID: 14504914
16 results